1.
Zhonghua Er Ke Za Zhi
; 61(8): 673-674, 2023 Aug 02.
Artigo
em Chinês
| MEDLINE
| ID: mdl-37528004
2.
Zhonghua Er Ke Za Zhi
; 60(7): 621-626, 2022 Jul 02.
Artigo
em Chinês
| MEDLINE
| ID: mdl-35768347
3.
Zhonghua Er Ke Za Zhi
; 60(4): 360-362, 2022 Apr 02.
Artigo
em Chinês
| MEDLINE
| ID: mdl-35385947
4.
Zhonghua Er Ke Za Zhi
; 60(1): 76-77, 2022 Jan 02.
Artigo
em Chinês
| MEDLINE
| ID: mdl-34986631
5.
Zhonghua Er Ke Za Zhi
; 59(8): 624-626, 2021 Aug 02.
Artigo
em Chinês
| MEDLINE
| ID: mdl-34333912
6.
Zhonghua Gan Zang Bing Za Zhi
; 29(1): 13-15, 2021 Jan 20.
Artigo
em Chinês
| MEDLINE
| ID: mdl-33541018
RESUMO
Cytomegalovirus hepatitis, especially infants with cholestatic liver disease or abnormal liver function, is of great concern to pediatricians. Previously, cytomegalovirus infection was the recognized cause of the disease. Therefore, a comprehensive scientific understanding of cytomegalovirus hepatitis requires an understanding of the basic knowledge of cytomegalovirus infection. Concurrently, it is necessary to standardize the indications of antiviral treatment in combination with the child's age, immune status and other potential diseases to avoid the abuse of antiviral drugs.
